search
Highlights
    Home  // . //  Oliver Wyman Health //  Slide Show: A New Role for Pharma in Healthcare Value Chain

    Slide Show: A New Role for Pharma in Healthcare Value Chain

    This illustrative example from the deck of Oliver Wyman's life sciences team shows how drugmakers can combine a range of services to meet the needs of patients, providers, and payers simultaneously in a holistic, integrated fashion.

    Table of Contents

      The illustrative example below from the deck of Oliver Wyman's life sciences team shows how drugmakers can combine a range of services to meet the needs of patients, providers, and payers simultaneously in a holistic, integrated fashion.

      True Value Chain Pharma Disruption is (Finally) Here to Stay

      In light of breaking news, the pharma value chain is definitely ripe for disruption. Here's how health plans, employers, and drug companies can adjust to the new normal.

      Healthcare Cost Transparency: Tipping Toward Strategic Imperative

      We asked in our November 2014 white paper Getting Ready for Price Transparency if this year would be the tipping point for healthcare transparency. It certainly seems that it's going that way. Oliver Wyman's Tomas Mikuckis highlights a number of examples across sectors that show how payers, regulators - and even a few providers - are jumping on the transparency bandwagon.

      New Report: Women Make 80% Of Buying Decisions But Represent Only 13% Of CEOs

      Our interviews and research unearth the visible and invisible forces contributing to healthcare's gender leadership gap.

      Fulfilling Your Five-Star Agenda

      The ideal Stars leader of tomorrow needs a specific skill set to produce consistently high Stars rating results for an organization.